Inside this portfolio
Identified stock classes24
Matched (%)99.59%
| Largest reported stocks | Portfolio weight |
|---|---|
| Novo Nordisk A/S | 12.96% |
| Eli Lilly & Co | 12.69% |
| Pfizer Inc | 6.38% |
| Kailera Therapeutics Inc | 6.21% |
| Viking Therapeutics Inc | 5.86% |
How to read these numbers
The day the fund recorded its holdings.
The share of the fund’s net assets that we could identify as common-stock classes.